Key statistics
On Friday, Tiziana Life Sciences Ltd (0RP:FRA) closed at 1.10, 61.76% above the 52 week low of 0.68 set on Apr 14, 2025.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
| Open | 1.10 |
|---|---|
| High | 1.10 |
| Low | 1.10 |
| Bid | -- |
| Offer | -- |
| Previous close | 1.16 |
| Average volume | 382.60 |
|---|---|
| Shares outstanding | 125.89m |
| Free float | 77.63m |
| P/E (TTM) | -- |
| Market cap | 174.99m USD |
| EPS (TTM) | -0.1136 USD |
Data delayed at least 15 minutes, as of Feb 13 2026 07:00 GMT.
More ▼
Announcements
- Tiziana Life Sciences Announces the Peer-Reviewed Publication of Clinical Study Results for Intranasal Foralumab
- Tiziana Life Sciences Announces Closing of Oversubscribed $8.8 Million Registered Direct Offering of Ordinary Shares
- Tiziana Life Sciences Announces Registered Direct Offering of up to approximately $17.6 Million
- Tiziana Life Sciences to Present at the 9th Annual Neuroscience Innovation Forum During J.P. Morgan Healthcare Conference Week in San Francisco
- Tiziana Files Annual Safety Report for Intranasal Foralumab with FDA
- Tiziana Life Sciences Announces Acquisition of Shares by Executive Chairman
- Tiziana Life Sciences to Ring the Closing Bell at Nasdaq
- Tiziana Life Sciences Doses First Patient in Phase 2 Alzheimer’s Clinical Trial
- Tiziana Life Sciences Announces Purchase of Shares by Chief Executive Officer
- Tiziana Life Sciences Announces Withdrawal of Proposed Public Offering
More ▼
